autoimmune startup

Actionable Insights Powered by AI

AbbVie Acquires Landos Biopharma to Enhance Post-Humira Immunology Pipeline

AbbVie, Landos Biopharma, Small acquisition, IBD (Inflammatory Bowel Disease) drug, Humira, Autoimmune startup, Immunology pipeline